Skip to content

Clinical observation of hemoperfusion combined with high flux dialysis to improve dialysis efficiency

Clinical observation of hemoperfusion combined with high flux dialysis to improve dialysis efficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057690
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodialysis patients

Interventions

1:Hemoperfusion

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18, regardless of gender; 2. Maintenance hemodialysis>3 months, regular hemodialysis 3 times/week, 4 hours/time; 3. Vascular access is not limited; 4. Voluntary test.

Exclusion criteria

Exclusion criteria: 1. Patients with coagulation disorder, severe bleeding tendency and active bleeding; 2. Severe malnutrition serum albumin<30g/L; 3. Long term dialysis is insufficient, Kt/V < 1.2; 4. Patients with low blood pressure and severe cardiopulmonary insufficiency; 5. Patients with acute infection, serious heart, lung, liver, nervous system diseases and other acute and critical diseases and malignant tumors.

Design outcomes

Primary

MeasureTime frame
Indole phenol sulfate;P-cresol;

Secondary

MeasureTime frame
Creatinine;Calcium;Phosphorus;parathyroid hormone;left ventricular thickness;SF36 scale;

Countries

china

Contacts

Public ContactYiwen Li

Zhejiang Provincial People's Hospital

yiwen1962@163.com+86 13456775925

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026